Former FDA Advisor on Eli Lilly's Antibody Treatment

2020-10-08 2

Dr. Dan Fagbuyi, ER physician and biodefense expert, joined TheStreet's Katherine Ross to discuss Eli Lilly's antibody treatment.

Videos similaires

India gives emergency use approval to Eli Lilly’s Covid antibody drug

Eli Lilly's COVID-19 antibody drug gets interim authorization in Canada

FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease

FDA Advisory Committee Unanimously Approves Eli Lilly's Alzheimer's Drug as Safe and Effective

FDA Approves Eli Lilly's Alzheimer's Drug, Slowing the Progression of the Brain-Wasting Disease

Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'

Eli Lilly's Earnings Soar as Diabetes and Weight Loss Drugs Fuel Blockbuster Quarter

Eli Lilly's COVID-19 drug gets U.S. authorization

Eli Lilly's COVID-19 drug gets U.S. authorization

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

Web Analytics